Skip to main content
E

Elytron

Elytron utilizes biotechnology and artificial intelligence to analyze vast collections of microorganisms and their derivatives, predicting their efficacy for crop protection and nutrition. This approach accelerates the development of biopesticides, addressing the need for sustainable agricultural solutions that reduce reliance on chemical pesticides.

Gent, Costa RicaFounded 2020
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

The agricultural industry faces increasing challenges in protecting crops from pests and diseases while minimizing the environmental impact of traditional chemical pesticides. Existing biopesticide development processes are often slow and inefficient, hindering the rapid adoption of sustainable agricultural solutions.

Solution

Elytron leverages biotechnology and artificial intelligence to accelerate the discovery and development of novel biopesticides and biofertilizers. The company analyzes extensive collections of microorganisms and their derivatives, employing AI-driven predictive models to identify promising candidates for crop protection and nutrition. This approach enables faster time-to-market for more robust and effective bioinputs, reducing the reliance on synthetic chemicals and promoting sustainable farming practices. Elytron's technology maps large banks of microorganisms and derivatives to predict their potential for crop protection and crop nutrition.

Target Audience

Elytron's primary customers are agricultural companies, crop protection manufacturers, and growers seeking sustainable and effective alternatives to chemical pesticides and fertilizers.

Features

  • AI-powered platform for predicting the efficacy of microorganisms and their derivatives in crop protection and nutrition
  • High-throughput screening and analysis of microbial libraries
  • Predictive modeling to identify novel biopesticide and biofertilizer candidates
  • Accelerated development timelines for bioinput products
This profile is AI-generated and may contain inaccuracies.